Regulatory Considerations on the Development of mRNA Vaccines.

Regulatory Considerations on the Development of mRNA Vaccines. Curr Top Microbiol Immunol. 2020 Jul 08;: Authors: Naik R, Peden K Abstract Developing traditional viral vaccines for infectious diseases usually takes years, as these are usually produced either by chemical inactivation of the virus or attenuation of the pathogen, processes that can take considerable time to validate and also require the live pathogen. With the advent of nucleic-acid vaccines (DNA and mRNA), the time to vaccine design and production is considerably shortened, since once the platform has been established, all that is required is the sequence of the antigen gene, its synthesis and insertion into an appropriate expression vector; importantly, no infectious virus is required. mRNA vaccines have some advantages over DNA vaccines, such as expression in non-dividing cells and the absence of the perceived risk of integration into host genome. Also, generally lower doses are required to induce the immune response. Based on experience in recent clinical trials, mRNA-based vaccines are a promising novel platform that might be useful for the development of vaccines against emerging pandemic infectious diseases. This chapter discusses some of the specific issues that mRNA vaccines raise with respect to production, quality, safety and efficacy, and how they have been addressed so as to allow their evaluation in clinical trials. PMID: 32638114 [PubMed - as supplied by publisher]
Source: Current Topics in Microbiology and Immunology - Category: Microbiology Tags: Curr Top Microbiol Immunol Source Type: research

Related Links:

Authors: Lackland DT, Sims-Robinson C, Jones Buie JN, Voeks JH Abstract The randomized clinical trial (RCT) has long been recognized as the 'gold standard' for developing evidence for clinical treatments and vaccines; however, the successful implementation and translation of these findings is predicated upon external validity. The generalization of RCT findings are jeopardized by the lack of participation of at-risk groups such as African Americans, with long-recognized disproportional representation. Distinct factors that deter participation in RCTs include distrust, access, recruitment strategies, perceptions of ...
Source: Ethnicity and Disease - Category: International Medicine & Public Health Tags: Ethn Dis Source Type: research
As some youth sports teams get started again, some summer camps and daycares are opening up, and we begin to think about school (or some form of it) in the fall, many parents are wondering: what do I do about getting that physical form I need for my child? Understandably, many families do not want to go to the doctor right now. They are worried about going anywhere, and especially worried about going to a medical office, where they are concerned they may end up around sick people. I want to say up front that most medical facilities are very aware of the risk, and take measures to make sure that patients can safely get the ...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Adolescent health Children's Health Parenting Source Type: blogs
Abstract The unprecedented pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening global health. The virus emerged in late 2019 and can cause a severe disease associated with significant mortality. Several vaccine development and drug discovery campaigns are underway. The SARS-CoV-2 main protease is considered a promising drug target, as it is dissimilar to human proteases. Sequence and structure of the main protease are closely related to those from other betacoronaviruses, facilitating drug discovery attempts based on previous lead compounds. Covalently binding peptidomimetic...
Source: Bioorganic and Medicinal Chemistry Letters - Category: Chemistry Authors: Tags: Bioorg Med Chem Lett Source Type: research
Pausing to check his map, Sam confirms that he is on the right track for his next delivery, only 2 kilometres left. He takes the opportunity to quench his thirst and check if his delivery load is securely attached to his back; some contain fragile vials of medicines and digital pills susceptible to damage if handled inappropriately. After making sure of the integrity of those packages, Sam takes a final look at his surroundings. “It’s quite peaceful with nobody around,” he thinks to himself and resumes his path.  Upon arrival at his destination, his gear is disinfected before he has access to the ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Artificial Intelligence Augmented Reality Digital Health Research Healthcare Design Healthcare Policy Telemedicine & Smartphones Virtual Reality fda gamification Fitbit covid19 Apple Watch WHO gaming roche MySugr Foldit A Source Type: blogs
Religions for Peace Interreligious Council of Albania distributing Covid relief supplies from the Multi-religious Humanitarian Fund. Credit: Erzen CarjaBy Prof. Azza KaramNEW YORK, Aug 4 2020 (IPS) — I have never been interested in religion or spirituality before, but I found myself tuning in to all sorts of on-line religion and spirituality related forums “in search of something.” These are the words of a 30-something single young, middle class man (born into a Protestant-Catholic family background) in a European country. The latter is known more for turning several churches into museums or shopping ce...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Civil Society Featured Global Headlines Health Human Rights Humanitarian Emergencies Inequity Religion TerraViva United Nations Source Type: news
ConclusionsCOVID-19 has become an everyday topic of discussion throughout the world, indicating the increasing number of COVID-19 cases, deaths and recoveries. The lessons learned from past pandemics such as social distancing, wearing masks, avoiding public gatherings and adherence to guidelines, along with personal hygiene, are the key measures that must be taken in order to live with COVID-19. Precautions for the elderly and pregnant women advised by medical authorities are to be strictly adhered to. These will help in reducing COVID-19 cases and in turn will reduce the pressure on hospitals to serve those in need. India...
Source: Journal of Public Health - Category: Health Management Source Type: research
The American Institute of Biological Sciences joined a coalition of 90 scientific, academic, and medical groups to express support for the continued use of human fetal tissue in biomedical research. In a July 28, 2020, letter to the National Institutes of Health (NIH) Human Fetal Tissue Research Ethics Advisory Board, the groups argued, in part: “The long-standing existing review process for fetal tissue research ensures that research using fetal tissue is scientifically meritorious, legal, and ethically sound. The legal framework for this research prohibits people from profiting from acquiring, receiving, or transf...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
On July 27, 2020, Republican lawmakers in the Senate unveiled a $1 trillion stimulus package to address the impacts of the ongoing coronavirus pandemic. The Health, Economic Assistance, Liability, and Schools Act or HEALS Act includes $105 billion in education funding; a “liability shield” to protect businesses, universities, schools, and hospitals from coronavirus-related lawsuits; another round of direct stimulus payments to American households; additional funding for the Paycheck Protection Program and emergency business loans; and a two-thirds reduction in emergency federal supplemental unemployment paymen...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
US Food and Drug Administration (FDA) Commissioner Stephen Hahn, MD, discusses the agency's role in responding to the COVID-19 pandemic. Recorded July 30, 2020. Related Article: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
Source: JAMA Author Interviews - Category: General Medicine Authors: Source Type: podcasts
Countries around the world have introduced stringent control measures to stop COVID-19 outbreaks growing, but now many find themselves facing the same situation again. From Melbourne to Miami, the relaxation of measures had led to increasing flare-ups, which in some places has already meant reclosing schools, businesses or travel routes. Within the U.S. and among different countries, places with wildly varying public-health policies have experienced wildly diverse outcomes. Most ominously, infections are rising rapidly in many places where they once were falling. So how do countries avoid an indefinite, unsustainable, cycl...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: Allergy & Immunology | Chemistry | Clinical Trials | Genetics | Infectious Diseases | Microbiology | Pandemics | Vaccines